Clinical Trials on High-Risk Secondary Myelofibrosis

Total 648 results

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis

Moderate and High Risk Myelofibrosis

China
Novartis Pharmaceuticals

Terminated

Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations. (ReTHINK)

Myelofibrosis With High Molecular Risk Mutations

Belgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
University Health Network, Toronto

Recruiting

Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis (ALLO-BAT)

Myelofibrosis | Bone Marrow Cancer | High-Risk Cancer

Canada
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Incyte Corporation

Active, not recruiting

JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis

Primary Myelofibrosis | Secondary Myelofibrosis

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis

Primary Myelofibrosis | Secondary Myelofibrosis

United States
Fred Hutchinson Cancer Center

Recruiting

Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis

Primary Myelofibrosis | Secondary Myelofibrosis

United States
Fred Hutchinson Cancer Center

Recruiting

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

Primary Myelofibrosis | Secondary Myelofibrosis

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis

Secondary Myelofibrosis

United States
Geron Corporation

Completed

Imetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis

Primary Myelofibrosis | Secondary Myelofibrosis | Myeloid Malignancies

United States
Institut für Klinische Krebsforschung IKF GmbH...
Celgene International II S.á.r.l.; Prof. F. Heidel, MH Hannover

Recruiting

Fedratinib in Combination With Nivolumab

Primary Myelofibrosis | Secondary Myelofibrosis

Germany
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis

Primary Myelofibrosis | Secondary Myelofibrosis

United States
Array BioPharma

Completed

A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors

AML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDS

United States, Australia, Italy, Spain, France, Switzerland, United Kingdom
George Washington University
University of North Carolina, Chapel Hill; Aga Khan University; Kenya Medical... and other collaborators

Recruiting

PRISMA Maternal and Newborn Health Study (PRiSMA-MNH)

Pregnancy, High Risk

Pakistan, Ghana, Kenya, India, Zambia
George Washington University

Recruiting

Validation of a Non-invasive Hemoglobin Measurement Device in Pregnancy and Postpartum in Kenya, Pakistan, and Zambia

Pregnancy, High Risk

Pakistan, Kenya, Zambia
London School of Hygiene and Tropical Medicine
Rawalpindi Medical College

Completed

Pharmacokinetics and Pharmacodynamics of Tranexamic Acid in Women Having Caesarean Section Birth [WOMAN-PharmacoTXA]

Pregnancy, High Risk

Pakistan, Zambia
University of Aarhus
Copenhagen University Hospital, Hvidovre

Completed

An Adapted Mindfulness-based Stress Reduction Program for Psycho-socially Vulnerable Pregnant Women.

Pregnancy, High Risk

Denmark
Ain Shams University

Completed

Frequency of Performing Umbilical Artery Doppler in the Third Trimester in High Risk Pregnancy

High Risk Pregnancy

Egypt
Northwestern University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaborators

Completed

Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial

High-risk Medications

United States
University Hospital, Lille

Completed

Perception of Risks Into Work During Pregnancy Among Post-partum Women in the Lille Metropolis (PERISTRAG)

Pregnancy, High Risk

France
University of British Columbia
National Institutes of Health (NIH)

Completed

Campus Health Intervention Projects UBC Site

High Risk Drinking

Canada
Southeast University, China

Recruiting

Machine Learning-based Early Clinical Warning of High-risk Patients

High-risk Patients | Risk Reduction | Machine Learning

China
National Cancer Institute (NCI)

Active, not recruiting

Decitabine in Treating Patients With Myelofibrosis

Primary Myelofibrosis | Secondary Myelofibrosis

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

P1101 in Treating Patients With Myelofibrosis

Primary Myelofibrosis | Secondary Myelofibrosis

United States
New York City Health and Hospitals Corporation
New York State Department of Health

Completed

A Patient Centered Intervention to Improve Health and Reduce Medicaid Costs

High-risk, High-cost Medicaid Services Users

United States
University of Ulm

Active, not recruiting

Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF (POMINC)

Primary Myelofibrosis | Secondary Myelofibrosis | Post-PV MF | PMF | SMF | Post-ET MF

Germany
Mayo Clinic
National Cancer Institute (NCI)

Completed

Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With Myelofibrosis

Primary Myelofibrosis | Anemia | Secondary Myelofibrosis

United States
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....

Not yet recruiting

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

High-risk (Secondary) Acute Myeloid Leukemia

China
Nursel Alp Dal

Completed

Guided Imagery on the Perceived Stress Level in High-Risk Pregnancies

High Risk Pregnancy

Turkey
Cairo University

Completed

Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman

Pregnancy | High Risk

Egypt
University of Utah

Completed

Use Of An In-Home Non-Stress Test Device For Remote Fetal Monitoring

High Risk Pregnancy

United States
Istituto Giannina Gaslini

Recruiting

Music Therapy and High-risk Pregnancy

High Risk Pregnancy

Italy
Fondazione GISE Onlus
University of Padova; Abiomed Inc.

Recruiting

The PROTECT-EU Study

High-risk PCI

Italy
Lo.Li.Pharma s.r.l

Completed

Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone.

Pregnancy, High Risk

Italy
Indiana University

Completed

Coconut Oil vs. Commercial Ultrasound Gel In Obstetric Ultrasounds

Pregnancy, High Risk

United States
Oregon Health and Science University
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Placenta Imaging Project (PIP)

High Risk Pregnancy

United States
University of Texas Southwestern Medical Center

Completed

Adjunctive Smart Phone Based Smoking Cessation Treatment

High-Risk Cancer
Mount Sinai Hospital, Canada
Ontario Mental Health Foundation

Unknown

Does Mid-Gestation Placental Function Assessment Reduce Psychological Distress in Women With High-Risk Pregnancies?

High-Risk Pregnancy

Canada
Beijing Anzhen Hospital

Recruiting

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention (ESCORT)

High-risk PCI | ECMO

China
Motao Zhu
Centers for Disease Control and Prevention

Recruiting

Behind the Wheel (BTW) Smartphone Application (BTW)

High-risk Driving Events

United States
Yalda Afshar, MD, PhD
University of California, Los Angeles

Recruiting

UCLA Perinatal Biospecimen Repository

Pregnancy | High-Risk Pregnancy

United States
VIVE - The Danish Center for Social Science Research
Yale University; Metodecentret - Center for Effective Innovation in Social...

Recruiting

The Effectiveness of MInding the Baby in a Danish Community Sample (MTB)

Pregnancy, High Risk | Family

Denmark
The University of Texas Health Science Center,...
Merck Sharp & Dohme LLC

Active, not recruiting

Use of an Educational Multimedia Tool Versus Routine Care for the Uptake of Postpartum LARC in High-Risk Pregnancies (SUSTAIN)

Pregnancy, High Risk | Contraception

United States
Università Politecnica delle Marche

Completed

A Therapy to Reduce Morbidity and Hospital Length of Stay of High-Risk Surgical Patients

High-Risk Surgical Patients

Italy
PETHEMA Foundation

Completed

Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia (LAMVYX)

Newly Diagnosed Secondary or High Risk AML

Spain
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosis

Chronic Myeloproliferative Disorders | Secondary Myelofibrosis

United States
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Azacitidine in Treating Patients With Myelofibrosis

Chronic Myeloproliferative Disorders | Secondary Myelofibrosis

United States
Suez Canal University

Completed

Clinical Evaluation of Chemically Cured Conventional Glass Ionomer After Light Emitting Diode Radiant Heat Enhancement

High Caries Risk Patients

Egypt
Tammy Moore

Active, not recruiting

Testing the Effectiveness of a Falls Prevention System

High Risk for Falling

United States
Cairo University

Unknown

Assessment of Inhibition of Biofilm Formation and Plaque Bacterial Count of Fluoride Varnish Containing Chlorhexidine and Cetylpyridinium Chloride Versus Conventional Fluoride Varnish

High Caries Risk Patients

Egypt
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Measurement of Cardiac Index Using an Implanted Central Venous Access Port in Patients Scheduled for Oncologic High-risk Surgery (ThermoD-PAC)

Oncologic High-risk Surgery

France

Clinical Trials on High-Risk Secondary Myelofibrosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations